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Abstract 
Pilot and open trials suggest that imagery-enhanced group cognitive behaviour therapy 
(CBT) is highly effective for social anxiety disorder (SAD).  However, before being 
considered reliable and generalisable, the effects of the intervention need to be replicated by 
clinicians in a setting that is independent of the protocol developers. The current study 
compared outcomes from clients with a principal diagnosis of SAD at the Australian clinic 
where the protocol was developed (n = 123) to those from an independent Canadian clinic (n 
= 46) to investigate whether the large effects would generalise. Trainee clinicians from the 
independent clinic ran the groups using the treatment protocol without any input from its 
developers. The treatment involved 12 two-hour group sessions plus a one-month follow-up.  
Treatment retention was comparable across both clinics (74% vs. 78%, ≥9/12 sessions) and 
the between-site effect size was very small and non-significant on the primary outcome 
(social interaction anxiety, d = .09, p = .752). Within-group effect sizes were very large in 
both settings (ds = 2.05 vs. 2.19), and a substantial minority (41%-44%) achieved clinically 
significant improvement at follow-up. Replication of treatment effects within an 
independent clinic and with trainee clinicians increases confidence that outcomes are 
generalisable. 
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Transportability of imagery-enhanced CBT for social anxiety disorder 
Social anxiety disorder (SAD) is one of the most common and earliest onset anxiety 
disorders (McEvoy, Grove, & Slade, 2011), and it is characterised by marked and persistent 
anxiety when exposed to potential scrutiny by others (American Psychiatric Association, 
APA, 2013). Cognitive behavioural therapy (CBT) is the recommended psychological 
treatment for SAD (National Institute for Health and Care Excellence, NICE, 2013) because 
it is both efficacious in research settings (Clark et al., 2003) and effective in real world 
clinical practice (McEvoy, Nathan, Rapee, & Campbell, 2012). Recent pilot and open trials 
of a novel imagery-enhanced group CBT protocol in a community mental health clinic 
yielded very large effect sizes that were comparable to individual CBT (McEvoy & 
Saulsman, 2014; McEvoy, Erceg-Hurn, Saulsman, & Thibodeau, 2015). However, before 
clinicians adopt a new treatment, it is important to demonstrate that the effects are 
generalisable to independent clinical services without direct supervision or input from the 
protocol developers. Evidence that research teams who report novel findings more 
frequently replicate such findings compared to independent researchers (Makel, Plucker, & 
Hegarty, 2012) suggests it is critical that effects are independently replicated before 
concluding that they are transportable to other settings (Tackett et al., 2017). 
Cognitive theorists suggest that individuals with SAD hold assumptions that others 
are likely to be critical and judgmental, and that there is a high cost to negative evaluation 
(Heimberg, Brozovich, & Rapee, 2014). Central to these models is that individuals with 
SAD form a mental representation of the self, creating a vivid impression of how others 
view them from an observer perspective. This mental representation is guided by internal 
cues (e.g., symptoms of anxiety such as warmth in cheeks), memories of previous social 
experiences, and observable feedback (e.g., ambiguous feedback such as yawns, perceived 
as signs of boredom rather than tiredness). When this internal self-representation is then 
compared to beliefs about the standards expected by the audience, individuals with SAD 
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invariably believe their performance falls woefully short. The perceived discrepancy 
between actual and expected performance then leads to a cascade of negative thoughts and 
emotions, as well as avoidance behaviours, which ultimately reinforce and maintain the 
negative self-image and consequently the perceived social threat. A distorted negative self-
image is therefore a key maintenance factor of social anxiety (Heimberg et al., 2014), which 
is targeted in imagery-enhanced CBT by encouraging clients to first identify negative 
predictions related to the self and others within mental imagery. Negative mental images are 
then used as predictions within behavioural experiments which, in turn, are designed to 
maximally violate the vivid expectancies (McEvoy, Saulsman, & Rapee, 2018). Other key 
therapy components include video feedback, which is used to directly challenge mental 
imagery of the anxious self, and imaginal (or imagery) rescripting, during which clients are 
guided within their imagination to relive and reappraise socially painful memories that 
encapsulate core negative beliefs about self and others.  
Heimberg et al.’s (2014) model of SAD also emphasises the potency of modifying 
affect by working within the imagery mode rather than the verbal mode. Imagery involves 
multisensory-perceptual representations that can have visual, somatic, auditory, olfactory, 
and/or gustatory elements, and which have particularly strong links to both positive and 
negative emotions (Holmes & Mathews, 2010). Negative mental imagery is common in 
socially anxious individuals and increases anxiety, avoidant behaviours, self-focused 
attention, negative self-appraisals, and social performance deficits (e.g., Hirsch, Meynen, & 
Clark, 2004; Makkar & Grisham, 2011). Experimental research has also demonstrated that 
mental imagery activates positive and negative affect more potently than verbal-linguistic 
activity (Holmes & Matthews, 2010), suggesting that working within the imagery mode in 
therapy may result in larger affective change. Therefore, imagery-enhanced CBT 
incorporates mental imagery into all therapy components that are designed to modify six key 
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maintaining factors: negative thoughts and images, avoidance, safety behaviours, negative 
self-images, self-focused attention, and negative core beliefs (McEvoy & Saulsman, 2014). 
Evidence for imagery-enhanced CBT for SAD is currently limited to a pilot study (N 
= 19, McEvoy & Saulsman, 2014) and an open trial (McEvoy et al., 2015) comparing a 
sample receiving imagery-enhanced CBT (n = 53) to historical controls (n = 129) who 
received the protocol without the imagery-enhancements. These preliminary studies 
demonstrated high retention (around 90% of clients receiving ≥9 of 12 sessions), very large 
effect sizes (ds~2.0), and a substantial minority of clients achieving normative functioning 
(~40%, McEvoy et al., 2015). While these early findings raise hopes for improved outcomes 
compared to alternative protocols, and are particularly impressive given that they were 
achieved through group CBT which is half as costly per patient to deliver as individual CBT 
(Mavranezouli et al., 2015), the transportability of imagery-enhanced group CBT to 
independent clinical settings is currently unknown.  
The aim of the present study was to benchmark outcomes achieved from imagery-
enhanced group CBT administered at an independent service to those observed at the clinic 
in which the protocol was originally developed. To maximise independence, the protocol 
was shared with clinicians who were based in a different country and who did not receive 
supervision, guidance, or consultation from any of the protocol developers. Graduate 
students, predoctoral residents, and postdoctoral fellows in clinical psychology administered 
the protocol at the independent site. The use of trainee therapists, compared to the more 
experienced therapists within the development clinic, provided a particularly rigorous test of 
whether the effects would replicate. Outcomes from the independent clinic were 
hypothesised to compare favourably to those from the development clinic with respect to 
patient retention, effect sizes, trajectories of change, and the proportion of clients achieving 
reliable and clinically significant change. 
Method 
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Participants 
Development clinic. Participants were 123 consecutive referrals to an Australian 
community mental health clinic (Centre for Clinical Interventions) from health professionals 
(general medical practitioners, psychiatrists, psychologists). Inclusion criteria: (a) principal 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; APA, 1994) SAD 
diagnosis, (b) not currently actively suicidal, self-harming, or psychotic, and (c) non-
treatment-interfering substance use. The Mini International Neuropsychiatric Interview 
(MINI PLUS 5.0; Sheehan et al., 2001) was administered by masters- or doctorate-level 
clinical psychologists. Written informed consent was provided and approval was received 
from the Hospital’s Human Research Ethics Committee (QI 2014_05). Development clinic 
participants were mostly single (79%) and 52% were unemployed. Around one quarter 
(27%) never completed high school, 36% had finished high school, 7% had a trade 
certificate, and 30% had completed a University degree. The most common comorbidities 
were Major Depression (45%), Generalised Anxiety Disorder (33%) and Dysthymic 
Disorder (7%). 
Independent clinic. Participants were 46 clients who presented for treatment for 
social anxiety to the University of Waterloo Centre for Mental Health Research (CMHR), an 
outpatient psychology training clinic that provides mental health services to students and 
members of the general public. Participants were referred by mental health providers in the 
community or university counselling services, or self-referred in response to advertisements. 
Inclusion criteria: (a) principal diagnosis of SAD based on the Mini Neuropsychiatric 
Interview for DSM-5 (MINI 7.0.0; Sheehan, 2014) administered by trained graduate-level or 
postdoctoral clinicians under the supervision of the last author (DM), and (b) not endorsing 
active and interfering suicidality or self-harm, mania, psychosis, or substance use. Written 
informed consent was provided and approval was received from the University’s Human 
Research Ethics Committee (#21956). The independent clinic sample primarily comprised 
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university students (85%). The most common comorbidities were Major Depressive 
Disorder (17%), Generalised Anxiety Disorder (17%), and Persistent Depressive Disorder 
(9%). See Tables 1 and 2 for more details.1 
Outcome Measures 
Social Interaction Anxiety Scale (SIAS) and Social Phobia Scale (SPS).  The 
SIAS and SPS (Mattick & Clarke, 1998) are 20-item measures of interaction and 
performance anxiety, respectively. The SIAS was the primary outcome and assesses 
cognitive, affective, and behavioural reactions to interaction situations. The SPS describes 
situations in which the person is observed by others. The 5-point response scale for both 
scales is Not at all, Slightly, Moderately, Very, or Extremely characteristic of me. Total 
scores range from 0 to 80. These scales have high twelve-week test-retest reliabilities (SIAS 
r = .92; SPS r = .93, Mattick & Clarke, 1998) and are sensitive to change (Cox, Ross, 
Swinson, & Direnfeld, 1998). In the current sample, McDonald’s omega composite 
reliability coefficients2 were high (SIAS ω= .84, SPS ω= .90). 
Brief Fear of Negative Evaluation-Straight Forwardly Worded (BFNE-S, 
Rodebaugh et al., 2004). The BFNE-S is an 8-item self-report measure of fear and concern 
about negative evaluation from others on a 5-point response scale, Not at all, Slightly, 
Moderately, Very, or Extremely characteristic of me. Total scores range from 8 to 40. The 
BFNE-S has demonstrated high reliability (α = .92) and construct validity in clinical samples 
(Weeks et al., 2005). In the current sample the composite reliability was high (ω= .83). 
Depression, Anxiety and Stress Scale (DASS-21). The DASS-21 (Lovibond & 
Lovibond, 1995) measures emotional symptoms over the previous week and has excellent 
psychometric properties in psychiatric settings (Page, Hooke, & Morrison, 2007). Total 
scores range from 0 to 126. Composite reliability was very high (ω = .88). 
Procedure & Treatment 
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The mean number of clients per group was 8.05 (SD = 1.99), with 14 and 7 groups 
run at the development and independent sites, respectively. Treatment comprised 12 weekly 
2-hour sessions plus a one-month follow-up. The independent clinic started groups in April 
and October of each calendar year. October groups (n = 3) included a four-week break over 
December and January when the clinic closed. Treatment integrity was facilitated by a 
manual with comprehensive therapist instructions, patient handouts, and worksheets. 
Development clinic groups were co-facilitated by two masters- or doctoral-level clinical 
psychologists or a clinical psychologist and intern. Independent clinic groups were run by 
two to three doctoral students or postdoctoral fellows in clinical psychology under the direct 
supervision of a licensed clinical psychologist with expertise in treating SAD (DM). 
Development clinic supervision involved weekly discussions with co-facilitators, reviews 
during a weekly clinical team meeting, and ad hoc discussions with a nominated clinical 
supervisor when required. Independent clinic supervision involved live observation or video 
review of each session followed by weekly 1-hour supervision meeting with the therapists to 
discuss group content and process. No formal assessment of protocol adherence was 
measured. The SIAS and SPS were administered at sessions 1, 4, 8, 12 and 1-month follow-
up, whereas the BFNE and DASS were administered prior to each session. 
The imagery-enhanced CBT protocol was modified from Rapee, Gaston, and 
Abbott’s (2009) group CBT manual by incorporating imagery-based strategies throughout 
(see McEvoy et al., 2018, for a detailed description). The protocol targets negative social-
evaluative thoughts and images, avoidance, safety behaviours, negative self-images, self-
focused attention, and negative core beliefs. Early sessions focus on socialisation to the 
model, and identifying and challenging negative social images about the past, present and 
future. Sessions then involve behavioural experiments to challenge negative social-
evaluative images experientially while reducing avoidance and the use of safety behaviours. 
Various within- and between-session exercises challenge the probability and cost of negative 
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evaluation, as well as self-images (via video-feedback). Attention training and focusing 
exercises reduce self-focused and environment-focused attention, and increase task-focused 
attention. Later sessions modify negative core beliefs via imaginal rescripting and promote 
long-term behavioural change via positive prospective imagery techniques. The one-month 
follow-up session involves a progress review, relapse prevention, and future goal-setting. 
Data analysis 
 Baseline Comparisons and Treatment Retention. The extent to which participants 
at the two sites differed on continuous variables was assessed with Welch t-tests, and by 
evaluating the size of mean differences and standardised mean differences (i.e., Cohen’s d). 
For categorical variables, differences in proportions were examined using Chi-square tests 
and by calculating confidence intervals using the Newcombe (2013) Hybrid-Score interval. 
Treatment retention was compared with respect to mean number of sessions attended, and 
the proportion of clients attending ≥9 sessions.  
 Outcome Analyses.  Unadjusted analyses were used to examine whether the size of 
treatment effects and treatment trajectories were comparable across sites, irrespective of any 
baseline differences in client characteristics. These analyses were conducted using linear 
mixed-effect regression models. Focused contrasts were used to evaluate whether treatment 
effect sizes were comparable across sites. We estimated the mean change from baseline to 
the final time point (1 month-follow up) at the development and independent sites, and then 
tested whether there was a significant difference in mean change between the sites. 
Standardised effect sizes (i.e., Cohen’s d values) were computed by dividing the 
unstandardised effects by the pooled pre-treatment standard deviation (Morris, 2008). The 
extent to which trajectories of change were comparable across sites was evaluated by 
examining plots of the trajectories and p-value for the time x site interaction. For reliable 
change (RC) and clinically significant change (CSC) analyses, we used the same criteria as 
McEvoy et al. (2015). The changes required to achieve RC on the SIAS and SPS were 8.84 
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and 10.66, respectively. The cutoff for CSC was defined as the mid-point between the means 
of clinical and normative samples (SIAS = 40.56, SPS = 31.61, Carleton et al., 2014). 
 Adjusted analyses were conducted to evaluate the comparability of treatment effect 
sizes and trajectories after controlling for baseline differences in client characteristics across 
sites. This was achieved by through a propensity score analysis (West et al., 2014). This 
involved matching the 46 independent site participants with 46 participants from the 
development site in such a way as to minimise baseline differences. Analyses were then 
rerun using a similar approach to the unadjusted analyses.  See supplementary materials for 
a full explanation of unadjusted and adjusted analyses and for details about software, data, 
and code. 
Results 
Baseline Comparisons 
 Development clinic clients were older, more likely to be married and have at least 
one comorbidity, and had higher DASS scores. Scores on the SIAS, SPS, BFNE, and 
gender, did not significantly differ across sites (see Tables 1 and 2).  
Treatment Retention 
 The average number of sessions attended was similar across sites (Independent site 
M = 9.98, SD = 3.03; Development site M = 9.63, SD = 3.63, difference = 0.35, 95% CI [- 
0.76, 1.44], d = 0.10). The percentage of clients receiving a high treatment dose (≥9 
sessions) was also similar (Development site = 78.26%; Independent site = 73.98%, 
difference = 4.28%, 95% CI [-11.20, 16.94], p = .567).  
Unadjusted Analyses 
 Within-site standardised changes were large, between-site differences were small and 
non-significant (Table 3, Figures 1 and 2), and the p-values for the time x site interaction 
were large (SIAS p = .989, SPS p = .845). BFNE-S and DASS trajectories were also similar 
across sites and the time x site interactions were non-significant (BFNE-S p = .051, DASS p 
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= .097). Eight clients had a pre-treatment SIAS score below the CSC cutoff and were 
therefore excluded from the RC and CSC analyses. Reliable improvement rates were high 
and similar across the sites (Development site = 79.47%, Independent site = 79.19%, 
difference = 0.28%, 95% CI [-14.04, 14.62], p = .948). A substantial minority of clients 
achieved CSC (Development site = 44.42%, Independent site = 40.77%, difference = 3.66%, 
95% CI [-12.39, 19.70], p = .533). On the SPS, 30 clients had pre-treatment scores below the 
CSC cutoff and were excluded from analyses. Reliable improvement was high across the 
development site (90.04%) and independent clinic (87.83%), difference = 2.21%, 95% CI [-
13.01, 17.43], p = .578. Rates of CSC were also high and similar across sites (Development 
site = 72.64%, Independent site 77.57%, difference = -4.93%, 95% CI [-18.03, 8.18], p = 
.331). 
Adjusted Analyses 
 Propensity score matching was successful as standardised mean differences at 
baseline after matching were ≤ 0.08 on all variables (ps ≥ .72). Within-site standardised 
changes were large, between-site differences were small (Table 4), treatment trajectories 
were very similar (Figures 3 and 4), and p-values for the time x site interaction were large (p 
= .893 for SIAS and p = .706 for SPS). The treatment trajectory for the BFNE-S was similar 
across sites, except that there was a more pronounced drop in symptoms between sessions 
11 and 12 in the independent sample (time by site interaction, p = .032). The DASS 
trajectories were similar (time x site interaction p = .336). Six clients were excluded from 
analyses for having pre-treatment SIAS scores below the CSC cutoff. Rates of reliable 
change were 80.07% at the development clinic and 79.40% at the independent site, 
difference = 0.67%, 95% CI [-14.72, 16.07], p = .887. CSC rates were 43.91% at the 
development clinic and 40.30% at the independent site, difference = 3.60%, 95% CI [-12.62, 
19.83], p = .551. On the SPS, 21 clients were excluded due to pre-treatment scores below the 
CSC cutoff. Of the remaining clients, 87.92% reliably improved at the development clinic 
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and 88.20% at the independent clinic, difference = -.28, 95% CI [-19.59, 19.02], p = .948. 
Around three-quarters experienced CSC (Development clinic = 75.69%, Independent clinic 
= 77.34%, difference = -1.65%, 95% CI [-18.70, 15.40], p = .767. 
Discussion 
Imagery-enhanced group CBT integrates established evidence-supported techniques 
that target theory-driven maintaining factors for SAD (Heimberg et al., 2014; Rapee et al., 
2009) with evidence from the emotion literature suggesting that modifying cognitions within 
the imagery mode may be more potent than predominantly working in the verbal mode 
(Holmes & Matthews, 2010). Preliminary outcomes have been promising, with high 
retention, large effect sizes, and improvements in the proportion of individuals achieving 
clinically significant change (McEvoy & Saulsman, 2014; McEvoy et al., 2015). However, it 
is critical to demonstrate that comparable effects can be achieved by clinicians who are 
independent from the protocol developers, which was the main aim of the current study. The 
hypothesis that the effectiveness of imagery-enhanced CBT would be transportable to an 
independent clinic when delivered by trainee therapists was supported. 
Clients at the development site, which is a community mental health clinic, were 
more likely to have comorbid disorders and symptoms, and to be married and older, than 
clients the independent site, which is a clinical unit within a university setting. However, the 
samples did not differ in gender distribution or on social anxiety symptom severity. Despite 
the differences across the samples and the absence of any input from the development site, 
the outcomes in terms of treatment retention and symptom change were remarkably similar. 
Approximately three-quarters of clients across both settings received a ‘high dose’ of 
treatment. Within-group effect sizes at both sites were very large on changes in social 
interaction anxiety (Cohen’s ds ~ 2.0), and were large on changes in performance anxiety, 
general anxiety and depression, and fear of negative evaluation. Trajectories of change were 
very similar across both sites on all outcomes, as were rates of reliable and clinically 
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significant change. Approximately 80% of clients across both sites achieved reliable change 
and around 40% were within the normative range of social interaction anxiety at follow-up. 
These rates were even higher for performance anxiety (88% and 76%, respectively). The 
unadjusted analyses indicated that outcomes were comparable despite differences in features 
of the treatment context or clients. The pattern of findings when using propensity score 
matching indicated that comparable outcomes were achieved from similar clients across the 
treatment settings. 
These findings strongly suggest that the outcomes from the development site are 
generalisable to other clinics, including psychology training settings with relatively 
inexperienced treating clinicians. It is important to note that the supervisor at the 
independent clinic is an expert in SAD (DM), but his role was restricted to that of clinical 
supervisor and, thus, it is impressive that the outcomes were virtually identical when the 
treatment manual was administered by trainee therapists from a geographically distinct team 
who received no input from the protocol developers3. It is important for future research to 
evaluate whether similar outcomes could be achieved when therapists deliver the 
intervention without supervision from a SAD specialist and in other contexts (e.g., private 
practice). 
The within-group effect sizes are comparable to some of the largest effect sizes in the 
literature from both group and individual therapy. A recent meta-analysis found that group 
and individual CBT yielded standardised mean differences of 0.92 and 1.19 compared to 
waitlist control, respectively (Mayo-Wilson et al., 2014). Within-group effects for waitlists 
in CBT trials tend to be very small, thus the effect sizes from imagery-enhanced CBT appear 
to compare very favourably to treatments within the meta-analysis. Imagery-enhanced group 
CBT required an average of around six therapist hours per client, compared to up to around 
20 hours for individual therapy (Clark et al., 2003). Although the evidence to date suggests 
that outcomes from imagery-enhanced group CBT compare favourably to individual CBT, a 
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direct comparison across group and individual formats is required to answer this question 
more definitively. 
Several limitations must be considered. First, neither site included a waitlist control 
group nor a credible alternative intervention to control for confounds (e.g., regression to the 
mean) or non-specific factors of therapy (e.g., expectancies). The fact that clients in both 
samples met diagnostic criteria for social anxiety disorder and reported severe symptoms 
suggests that they were unlikely to remit over the 12-week intervention period, but 
controlled effects are likely to be somewhat smaller than the within-group effect sizes 
reported here. Second, although regular supervision was provided, treatment fidelity and 
therapist competence were not formally assessed. Although this issue means that we cannot 
ensure that all treatment components were delivered as prescribed in the manual, it is 
nonetheless reassuring that comparable effects were achieved across sites under these 
conditions, which provides some external validity for the findings. The manual includes 
very detailed therapist instructions and scripts, along with detailed client handouts and 
worksheets to guide each technique, which likely facilitated rapid training of new therapists 
at the independent clinic as well as a high degree of fidelity. Third, inter-rater reliability for 
pre-treatment diagnoses was not assessed, although self-reported symptom severity was very 
similar across sites at pre-treatment. Fourth, self-reported outcomes are susceptible to social 
desirability biases, so clinician-administered, behavioural, and psychophysiological 
measures would be informative.  
The present study replicated the retention rates and large effect sizes from imagery-
enhanced group CBT observed in the clinic that developed the treatment protocol within an 
independent clinic that received no input from the protocol developers. These findings 
increase confidence that imagery-enhanced CBT produces strong and transportable effects. 
Future research that directly compares imagery-enhanced group CBT to a credible 
alternative treatment is required to build the case that imagery-enhancements improve 
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outcomes beyond protocols that include some targeted imagery-based interventions (e.g., 
video-feedback) but do not comprehensively modify negative social-evaluative images more 
broadly within the imagery mode rather than the verbal mode. Comparisons between 
individual and group imagery-enhanced CBT would also be informative to ensure that 
comparable outcomes are achieved across treatment formats, or indeed whether effects may 
be even larger individually, and to directly compare cost-effectiveness.
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Footnotes 
1 Ethnicity data were only collected for around half the patients in the 
Development Clinic, 76% of whom identified as Anglo/European Australian, 10% as 
Asian Australian, and 14% as “another ethnicity”. Ethnicity data were not collected at 
the Independent Clinic. 
2 McDonald’s omega is a generalisation of Cronbach’s alpha psychometricians 
recommend be reported instead, primarily because alpha tends to underestimate the 
reliability of psychological measures. For an overview, see McNeish, D. (in press). 
Thanks coefficient alpha, we’ll take it from here. Psychological Methods. doi: 
10.1037/met0000144. 
3 DM contributed to the design of a current randomised controlled trial comparing 
imagery-enhanced to verbally-based group CBT, and is a co-author on that protocol 
paper (McEvoy et al., 2017). However, to date, DM has not met or spoken with the 
protocol developers. The protocol was provided electronically, delivered without 
supervision from the protocol developers, and all communication has been via email. 
McEvoy, P. M., Moulds, M. L., Grisham, J. R., Holmes, E. A., Moscovitch, D. A., 
Hendrie, D., et al. (2017). Assessing the efficacy of imagery-enhanced cognitive 
behavioral group therapy for social anxiety disorder: study protocol for a randomized 
controlled trial. Contemporary Clinical Trials, 60, 34-41. 
doi.org/10.1016/j.cct.2017.06.010 
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Table 1 
 
Comparison of Categorical Variables at Pre-Treatment  
  Site   Difference 
Variable Development Independent 
 
Est 95% CI p 
At least 1 comorbidity (%) 73.98 56.52 
 
17.46 1.76, 33.34 .029 
Married (%) 9.48 0.00 
 
9.48 0.75, 16.19 .031 
Female (%) 58.54 54.35 
 
4.19 -11.94, 20.62 .624 
 
Note. Est = Point-estimate of difference in percentages; 95% CI = lower and upper limits of the 95% confidence interval around the difference; p = 
p value 
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Table 2 
Comparison of Continuous Variables at Pre-Treatment  
  Site   Unstandardized 
Mean Difference 
  Standardized 
Mean Difference 
    
 
Development 
 
Independent 
    
Variable M SD 
 
M SD 
 
Est 95% CI 
 
d 95% CI 
 
p 
Age (years) 28.54 10.76 
 
22.87 5.98 
 
5.67 3.08, 8.26 
 
0.58 0.24, 0.93 
 
<.001 
DASS 61.52 21.38 
 
51.98 24.75 
 
9.54 1.20, 17.88 
 
0.43 0.08, 0.77 
 
.025 
SPS 44.49 13.24 
 
40.80 15.08 
 
3.70 -1.38, 8.77 
 
0.27 -0.07, 0.61 
 
.151 
SIAS 59.04 9.85 
 
58.41 11.15 
 
0.63 -3.13, 4.39 
 
0.06 -0.28, 0.40 
 
.739 
BFNE-S 22.76 5.59 
 
22.56 5.23 
 
0.21 -1.66, 2.07 
 
0.04 -0.31, 0.38 
 
.825 
 
Note. Est = Point-estimate of difference in percentages; 95% CI = lower and upper limits of the 95% confidence interval around the difference; p = 
p value for the difference in means; DASS= Depression, Anxiety and Stress Scale total score; SPS = Social Phobia Scale; SIAS = Social Interaction 
Anxiety Scale; BFNE-S = Brief Fear of Negative-Evaluation Straightforwardly worded version
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Table 3 
Unadjusted Analyses - Mean Change from Pre-treatment to Follow-Up 
Measure M SE 
 
d p 
       
SIAS 
      
 
Development 21.06 1.49 
 
2.07 
 
 
Independent 20.18 2.37 
 
1.98 
 
 
Difference 0.89 2.80 
 
0.09 .752 
SPS 
      
 
Development 22.82 1.42 
 
1.65 
 
 
Independent 19.90 2.24 
 
1.44 
 
 
Difference 2.91 2.65 
 
0.21 .273 
BFNE-S 
     
 
Development 8.74 0.64 
 
1.60 
 
 
Independent 9.44 1.02 
 
1.72 
 
 
Difference -0.69 1.21 
 
-0.13 .565 
DASS 
      
 
Development 29.33 3.17 
 
1.29 
 
 
Independent 23.75 5.11 
 
1.05 
 
  Difference 5.58 6.01 
 
0.25 .353 
 
Note. SIAS = Social Interaction Anxiety Scale; SPS = Social Phobia Scale; BFNE-S = 
Brief Fear of Negative-Evaluation Straightforwardly worded version; DASS= 
Depression, Anxiety and Stress Scale total score; Development = Development site; 
Independent = Independent site; Development and Independent site effects are within-
group effects; Difference = Between-group effects; d = standardized effect sizes; p = 
p value for test of mean difference in outcome between sites.  Pooled pre-treatment 
standard deviations used to compute the standardized effect sizes were 10.181 (SIAS), 
13.808 (SPS), 5.474 (BFNE), and 22.689 (DASS). 
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Table 4 
Adjusted Analyses - Mean Change from Pre-treatment to Follow-Up 
Measure M SE   d p 
SIAS       
 
Development 22.25 2.20 
 
2.19 
 
 
Independent 20.86 2.30 
 
2.05 
 
 
Difference 1.39 3.18 
 
0.14 .663 
SPS       
 
Development 20.48 1.81 
 
1.48 
 
 
Independent 20.35 1.87 
 
1.47 
 
 
Difference 0.13 2.60 
 
0.01 .961 
BFNE-S 
     
 
Development 9.11 0.94 
 
1.66 
 
 
Independent 9.62 0.97 
 
1.76 
 
 
Difference -0.51 1.35 
 
-0.09 .705 
DASS       
 
Development 22.25 3.05 
 
0.98 
 
 
Independent 24.42 3.16 
 
1.08 
 
  
Difference -2.17 4.39   -0.10 .621 
 
Note. SIAS = Social Interaction Anxiety Scale; SPS = Social Phobia Scale; BFNE-S = 
Brief Fear of Negative-Evaluation Straightforwardly worded version; DASS= 
Depression, Anxiety and Stress Scale total score; Development = Development site; 
Independent = Independent site; Development and Independent site effects are within-
group effects; Difference = Between-group effects; d = standardized effect sizes; p = 
p value for test of mean difference in outcome between sites.  Pooled pre-treatment 
standard deviations used to compute the standardized effect sizes were 10.181 (SIAS), 
13.808 (SPS), 5.474 (BFNE), and 22.689 (DASS). 
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Figure 1. Unadjusted Analyses - Trajectories of Symptom Change for Social 
Interaction Anxiety Scale (SIAS) and Social Phobia Scale (SPS) 
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Figure 2. Unadjusted Analyses - Trajectories of Symptom Change for Brief Fear of 
Negative Evaluation (BFNE-S) and Depression, Anxiety, and Stress Scale (DASS) 
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Figure 3. Adjusted Analyses - Trajectories of Symptom Change for Social Interaction 
Anxiety Scale (SIAS) and Social Phobia Scale (SPS) 
Transportability of Imagery-Enhanced CBT   29 
 
 
 
Figure 4. Adjusted Analyses - Trajectories of Symptom Change for Brief Fear of 
Negative Evaluation (BFNE-S) and Depression, Anxiety, and Stress Scale (DASS) 
